Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is Chamberlain, Jeffrey S  [Clear All Filters]
A
Arnett, ALH, Garikipati D, Wang Z, Tapscott SJ, Chamberlain JS.  2011.  Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector.. Frontiers in microbiology. 2:220. Abstract
B
Blankinship, MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL, Miller AD, Miller AD, Chamberlain JS.  2004.  Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.. Molecular therapy : the journal of the American Society of Gene Therapy. 10(4):671-8. Abstract
K
Kimura, E, Han JJ, Li S, Fall B, Ra J, Haraguchi M, Tapscott SJ, Chamberlain JS.  2008.  Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.. Human molecular genetics. 17(16):2507-17. Abstract
W
Wang, Z, Tapscott SJ, Chamberlain JS, Storb R.  2011.  Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials.. Frontiers in microbiology. 2:201. Abstract
Wang, Z, Chamberlain JS, Tapscott SJ, Storb R.  2009.  Gene therapy in large animal models of muscular dystrophy.. ILAR journal / National Research Council, Institute of Laboratory Animal Resources. 50(2):187-98. Abstract
Wang, Z, Storb R, Lee D, Kushmerick MJ, Chu B, Berger C, Arnett A, Allen J, Chamberlain JS, Riddell SR et al..  2010.  Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging.. Molecular therapy : the journal of the American Society of Gene Therapy. 18(3):617-24. Abstract
Wang, Z, Storb R, Halbert CL, Banks GB, Butts TM, Finn EE, Allen JM, Miller AD, Chamberlain JS, Tapscott SJ.  2012.  Successful Regional Delivery and Long-term Expression of a Dystrophin Gene in Canine Muscular Dystrophy: A Preclinical Model for Human Therapies.. Molecular therapy. 2(8):1501-7. Abstract